Official Journal of the Society of Radiopharmaceutical Sciences

Nuclear Medicine and Biology publishes original research addressing all aspects of radiopharmaceutical science for imaging as well as therapeutic applications. More specifically the synthesis (automated and manual), in vitro and ex vivo studies, in vivo biodistribution by dissection or imaging, radiopharmacology, radiopharmacy of new radiopharmaceuticals. Translational studies of novel targeted radiopharmaceuticals, e.g. first in human use, are warmly welcomed. In addition, in vivo imaging studies using radioactive tracers for physiological and pathophysiological research or drug discovery support are welcome. In all cases, the importance of the target to an unmet clinical need should be the first consideration.

These multidisciplinary studies should validate the mechanism of localization whether the tracer is based on binding to a receptor, enzyme, antigen, or another well-defined target. The studies should be aimed at evaluating how the chemical and radiopharmaceutical properties affect pharmacokinetics, pharmacodynamics, or therapeutic efficacy. Ideally, the study would address the sensitivity of the tracer to changes in disease or treatment, although studies validating mechanism alone are acceptable as well. In the case of therapeutic radiopharmaceuticals, the specificity of labeled compound localization and therapeutic effect should be addressed.

If the synthesis of a new radiopharmaceutical is submitted without in vitro or in vivo data, then the uniqueness of the chemistry must be emphasized and should provide a substantial improvement over existing methodologies.

Articles related to radiopharmacy, addressing the issues of preparation, automation, quality control, dispensing, and regulations applicable to qualification and administration of radiopharmaceuticals to humans, are also welcome if the article provides a significant impact on the field.

Editor-in-Chief
Albert Windhorst
VU University Medical Center Department of Radiology and Nuclear Medicine, Amsterdam, Netherlands
Associate Editor
Jason Lewis
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Yasuhiro Magata
Hamamatsu University School of Medicine, Hamamatsu, Japan
Editors
Carolyn J. Anderson
University of Pittsburgh, Pittsburgh, Pennsylvania, United States
Yasushi Arano
Chiba University, Chiba, Japan
Sylvie Chalon
University of Tours, Tours, France
Bart Cornelissen
Churchill Hospital, Oxford, United Kingdom
Paul Cumming
University Clinic of Nuclear Medicine, Inselspital, University Hospital Bern, Bern University, Bern, Switzerland
Cathy S. Cutler
Brookhaven National Laboratory, Upton, New York, United States
Ekaterina Dadachova
University of Saskatchewan, USA
Timothy DeGrado
Mayo Clinic Arizona, Scottsdale, Arizona, United States
Winnie Deuther-Conrad
Helmholtz Centre Dresden-Rossendorf Institute of Radiopharmaceutical Cancer Research, Leipzig, Germany
Frederic Dolle
French Alternative Energies and Atomic Energy Commission Frederic Joliot Hospital Service, Orsay, France
Adriano Duatti
University of Ferrara, Ferrara, Italy
Heather M. Hennkens
University of Missouri, Columbia, Missouri, United States
Andrew G. Horti
Johns Hopkins University, Baltimore, Maryland, United States
Gary D. Hutchins
Indiana University Purdue University at Indianapolis, Indianapolis, Indiana, United States
Michelle L. James
Stanford University School of Medicine, Molecular Imaging Program at Stanford, Stanford,, California, United States
Jae M. Jeong
Seoul National University College of Medicine, Seoul, South Korea
Hongmei Jia
Beijing Normal University, Beijing, China
Silvia S. Jurisson
University of Missouri, Columbia, Missouri, United States
Hank F. Kung
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Suzanne E. Lapi
University of Alabama at Birmingham, Birmingham, Alabama, United States
Jeanne Link
Oregon Health & Science University, Portland, Oregon, United States
Zhonglin Liu
University of Arizona, Tucson, Arizona, United States
Rob Mairs
Beatson Institute for Cancer Research, Glasgow, United Kingdom
David A. Mankoff
Penn Medicine, United States
Yubin Miao
University of Colorado Denver Department of Radiology, Aurora, Colorado, United States
Thomas L. Mindt
Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria
Eyal Mishani
Hebrew University of Jerusalem, Jerusalem, Israel
Giancarlo Pascali
Australian Nuclear Science and Technology Organisation, Kirrawee, Australia
Buck E. Rogers
Washington University in Saint Louis School of Medicine, Saint Louis, Missouri, United States
Mary R. Rusckowski
University of Massachusetts Medical School, Worcester, Massachusetts, United States
Sally W. Schwarz
Washington University in Saint Louis School of Medicine, Saint Louis, Missouri, United States
Nicholas Seneca
Novartis Institutes for BioMedical Research Basel, Basel, Switzerland
Julie Sutcliffe
University of California Davis Biomedical Engineering Department, Sacramento, California, United States
Samantha Terry
King's College London, London, United Kingdom
Mathew L. Thakur
Thomas Jefferson University Department of Radiology, Philadelphia, Pennsylvania, United States
John F. Valliant
McMaster University, Hamilton, Ontario, Canada
David Vera
University of California San Diego School of Medicine, La Jolla, California, United States
Nerissa Viola
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
Michael Zalutsky
Duke University School of Medicine, Durham, North Carolina, United States
Xianzhong Zhang
Xiamen University, Xiamen, China
Founder Editor
J. Sternberg †
Emeritus Editor
William Eckelman